Etid klinik pou Emofili B nan Tennessee
4 etid pou Emofili B ap chèche patisipan nan sit nan Tennessee.
Vil nan Tennessee
Tèks ofisyèl etid la (Anglè)
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
- St. Jude Children's Research Hospital, Memphis
Ap rekriteFaz 3
138 Months – 206 Months · Gason · Mizajou Sep 16, 2026 · NCT07080905A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
- Vanderbilt University Medical Center, Nashville
Ap rekriteFaz 1/2
Laj 2 ak plis · Gason · Mizajou Sep 11, 2026 · NCT06379789ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- St. Jude Children's Research Hospital, Memphis
- Vanderbilt University Medical Center, Nashville
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 17, 2026 · NCT04398628SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Vanderbilt University Medical Center, Nashville
Ap rekriteFaz 4
Laj 12 a 100 · Tout sèks · Mizajou Jan 12, 2026 · NCT04647227Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.